Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors: clinical burden, patient-reported outcomes, and treatment response

References

• Alinaghi F, Calov M, Kristensen LE, Wu JJ, Thyssen JP, Egeberg A. Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol 2019;80:251–65.
   PubMed Web of Science ®Google Scholar
• Rech J, Sticherling M, Stoessel D, Biermann MHC, Häberle BM, Reinhardt M. Psoriatic arthritis epidemiology, comorbid disease profiles and risk factors: results from a claims database analysis. Rheum Adv Pract 2020;4:rkaa033.
   PubMedGoogle Scholar
• FitzGerald O, Ogdie A, Chandran V, Coates LC, Kavanaugh A, Tillett W, et al. Psoriatic arthritis. Nat Rev Dis Primers 2021;7:59.
   PubMed Web of Science ®Google Scholar
• Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med 2017;376:957–70.
   PubMed Web of Science ®Google Scholar
• Kaeley GS, Eder L, Aydin SZ, Gutierrez M, Bakewell C. Enthesitis: a hallmark of psoriatic arthritis. Semin Arthritis Rheum 2018;48:35–43.
   PubMed Web of Science ®Google Scholar
• Freeston J, Coates LC, Helliwell PS, Hensor EMA, Wakefield RJ, Emery P, et al. Is there subclinical enthesitis in early psoriatic arthritis? A clinical comparison with power doppler ultrasound. Arthritis Care Res 2012;64:1617–21.
   PubMed Web of Science ®Google Scholar
• Pittam B, Gupta S, Harrison NL, Robertson S, Hughes DM, Zhao SS. Prevalence of extra-articular manifestations in psoriatic arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 2020;59:2199–206.
   PubMed Web of Science ®Google Scholar
• Polachek A, Li S, Chandran V, Gladman D. Clinical enthesitis in a prospective longitudinal psoriatic arthritis cohort: incidence, prevalence, characteristics and outcome. Arthritis Care Res (Hoboken) 2017;69:1685–91.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Karki C, Palmer JB, Etzel CJ, Kavanaugh A, Ritchlin CT, et al. Clinical characteristics, disease activity, and patient-reported outcomes in psoriatic arthritis patients with dactylitis or enthesitis: results from the corrona psoriatic arthritis/spondyloarthritis registry. Arthritis Care Res (Hoboken) 2017;69:1692–9.
   PubMed Web of Science ®Google Scholar
• Mathew AJ, Glintborg B, Krogh NS, Hetland ML, Østergaard M. Enthesitis in patients with psoriatic arthritis and axial spondyloarthritis – data from the Danish nationwide DANBIO registry. Semin Arthritis Rheum 2022;52:151948.
   PubMed Web of Science ®Google Scholar
• Orbai A-M, Birt JA, Holdsworth EA, Booth N, Malatestinic WN, Sprabery AT, et al. Impact of enthesitis on psoriatic arthritis patient-reported outcomes and physician satisfaction with treatment: data from a multinational patient and physician survey. Rheumatol Ther 2020;7:937–48.
   PubMed Web of Science ®Google Scholar
• Orbai A-M, de Wit M, Mease PJ, Callis Duffin K, Elmamoun M, Tillett W, et al. Updating the psoriatic arthritis (PsA) core domain set: a report from the PsA workshop at OMERACT 2016. J Rheumatol 2017;44:1522–8.
   PubMed Web of Science ®Google Scholar
• Mease PJ. Enthesitis in psoriatic arthritis (Part 3): clinical assessment and management. Rheumatology (Oxford) 2020;59:i21–i28.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Van den Bosch F, Sieper J, Xia Y, Pangan AL, Song I-H. Performance of 3 enthesitis indices in patients with peripheral spondyloarthritis during treatment with Adalimumab. J Rheumatol 2017;44:599–608.
   PubMed Web of Science ®Google Scholar
• Simons N, Degboé Y, Barnetche T, Cantagrel A, Ruyssen-Witrand A, Constantin A. Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes. Clin Exp Rheumatol 2020;38:508–15.
   PubMed Web of Science ®Google Scholar
• Kerschbaumer A, Smolen JS, Dougados M, de Wit M, Primdahl J, McInnes I, et al. Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis 2020;79:778–86.
   PubMed Web of Science ®Google Scholar
• McInnes IB, Sawyer LM, Markus K, LeReun C, Sabry-Grant C, Helliwell PS. Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes. RMD Open 2022;8:e002074.
   PubMed Web of Science ®Google Scholar
• Colombo D, Frassi M, Mariano GP, Fusaro E, Lomater C, Del Medico P, et al. Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an observatioNal lOngitudinal study of real-life clinical practice) observational longitudinal study. BMC Rheumatol 2022;6:57.
   PubMedGoogle Scholar
• Mathew AJ, Sutton M, Pereira D, Gladman DD, Chandran V. Effectiveness of disease-modifying antirheumatic drugs for enthesitis in a prospective longitudinal psoriatic arthritis cohort. J Rheumatol 2022;49:1020–5.
   PubMed Web of Science ®Google Scholar
• Brahe CH, Ørnbjerg LM, Jacobsson L, Nissen MJ, Kristianslund EK, Mann H, et al. Retention and response rates in 14261 PsA patients starting TNF inhibitor treatment – results from 12 countries in EuroSpA. Rheumatology (Oxford) 2020;59:1640–50.
   PubMed Web of Science ®Google Scholar
• Linde L, Ørnbjerg LM, Rasmussen SH, Love TJ, Loft AG, Závada J, et al. Commonalities and differences in set-up and data collection across European spondyloarthritis registries – results from the EuroSpA collaboration. Arthritis Res Ther 2023;25:205.
   PubMed Web of Science ®Google Scholar
• Mulder MLM, Wenink MH, Vriezekolk JE. Being overweight is associated with not reaching low disease activity in women but not men with psoriatic arthritis. Rheumatology (Oxford) 2022;61:770–4.
   PubMedGoogle Scholar
• Aouad K, Moysidou G, Rakotozafiarison A, Fautrel B, Gossec L. Outcome measures used in psoriatic arthritis registries and cohorts: a systematic literature review of 27 registries or 16,183 patients. Semin Arthritis Rheum 2021;51:888–94.
   PubMed Web of Science ®Google Scholar
• Ramiro S, Smolen JS, Landewé R, van der Heijde D, Gossec L. How are enthesitis, dactylitis and nail involvement measured and reported in recent clinical trials of psoriatic arthritis? A systematic literature review. Ann Rheum Dis 2018;77:782–3.
   PubMed Web of Science ®Google Scholar
• Antoni C, Krueger GG, de Vlam K, Birbara C, Beutler A, Guzzo C, et al. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 2005;64:1150–7.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Gladman DD, Ritchlin CT, Ruderman EM, Steinfeld SD, Choy EHS, et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2005;52:3279–89.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Gladman DD, Collier DH, Ritchlin CT, Helliwell PS, Liu L, et al. Etanercept and methotrexate as monotherapy or in combination for psoriatic arthritis: primary results from a randomized, controlled phase III trial. Arthritis Rheumatol 2019;71:1112–24.
   PubMed Web of Science ®Google Scholar
• Kavanaugh A, van der Heijde D, McInnes IB, Mease P, Krueger GG, Gladman DD, et al. Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial. Arthritis Rheum 2012;64:2504–17.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Fleischmann R, Deodhar AA, Wollenhaupt J, Khraishi M, Kielar D, et al. Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a phase 3 double-blind randomised placebo-controlled study (RAPID-PsA). Ann Rheum Dis 2014;73:48–55.
   PubMed Web of Science ®Google Scholar
• Lopez-Medina C, Chevret S, Molto A, Sieper J, Duruöz T, Kiltz U, et al. Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study. RMD Open 2021;7:e001728.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Liu M, Rebello S, Hua W, McLean RR, Hur P, et al. Disease characteristics, quality of life, and work productivity by enthesitis site: real-world data from the US Corrona psoriatic arthritis/spondyloarthritis registry. J Rheumatol 2021;48:367–75.
   PubMed Web of Science ®Google Scholar
• Sunar I, Ataman S, Nas K, Kilic E, Sargin B, Kasman SA, et al. Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study. Rheumatol Int 2020;40:283–94.
   PubMed Web of Science ®Google Scholar
• Orbai A-M, Perin J, Gorlier C, Coates LC, Kiltz U, Leung YY, et al. Determinants of patient-reported psoriatic arthritis impact of disease: an analysis of the association with sex in 458 patients from fourteen countries. Arthritis Care Res (Hoboken) 2020;72:1772–9.
   PubMed Web of Science ®Google Scholar
• de Vlam K, Steinfeld S, Toukap AN, de Vlam K, van den Bosch F, Joos R, et al. The burden of psoriatic arthritis in the biologics era: data from the Belgian epidemiological psoriatic arthritis study. Rheumatology (Oxford) 2021;60:5677–85.
   PubMedGoogle Scholar
• Furer V, Wollman J, Levartovsky D, Aloush V, Elalouf O, Sarbagil-Maman H, et al. Sex-based differences in sonographic and clinical findings among patients with psoriatic arthritis. J Rheumatol 2023;50:197–203.
   PubMedGoogle Scholar
• Polachek A, Furer V, Zureik M, Nevo S, Mendel L, Levartovsky D, et al. Role of ultrasound for assessment of psoriatic arthritis patients with fibromyalgia. Ann Rheum Dis 2021;80:1553–8.
   PubMed Web of Science ®Google Scholar
• Bakirici S, Solmaz D, Al Osaimi N, Dalkilic E, Can M, Erden A, et al. What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life? Clin Exp Rheumatol 2019;37:808–12.
   PubMed Web of Science ®Google Scholar
• Baraliakos X, Sewerin P, de Miguel E, Pournara E, Kleinmond C, Wiedon A, et al. Achilles tendon enthesitis evaluated by MRI assessments in patients with axial spondyloarthritis and psoriatic arthritis: a report of the methodology of the ACHILLES trial. BMC Musculoskelet Disord 2020;21:767.
   PubMed Web of Science ®Google Scholar
• Husni ME, Kavanaugh A, Murphy F, Rekalov D, Harrison DD, Kim L, et al. Efficacy and safety of intravenous golimumab through one year in patients with active psoriatic arthritis. Arthritis Care Res (Hoboken) 2020;72:806–13.
   PubMed Web of Science ®Google Scholar
• Carron P, Varkas G, Cypers H, Van Praet L, Elewaut D, Van den Bosch F, et al. Anti-TNF-induced remission in very early peripheral spondyloarthritis: the CRESPA study. Ann Rheum Dis 2017;76:1389–95.
   PubMed Web of Science ®Google Scholar
• Kaeley GS. Enthesitis in psoriatic arthritis (Part 2): imaging. Rheumatology (Oxford) 2020;Suppl_1:15–20.
   Google Scholar